HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Grassi Selected Research

Irinotecan (Camptosar)

10/2014Response to targeted therapy in urachal adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paolo Grassi Research Topics

Disease

22Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 01/2014
6Neoplasms (Cancer)
10/2018 - 01/2014
5Neoplasm Metastasis (Metastasis)
10/2018 - 01/2014
5Prostatic Neoplasms (Prostate Cancer)
11/2017 - 10/2015
4Disease Progression
01/2020 - 10/2014
3Kidney Neoplasms (Kidney Cancer)
10/2018 - 01/2014
2Carcinoma (Carcinomatosis)
11/2017 - 09/2016
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019
1Circulating Neoplastic Cells
10/2018
1Inappropriate ADH Syndrome (SIADH)
11/2017
1Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2017
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2016
1Cardiovascular Diseases (Cardiovascular Disease)
09/2016
1Heart Diseases (Heart Disease)
09/2016
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
09/2016
1Enteritis
12/2014
1Rectal Neoplasms (Rectal Cancer)
12/2014
1Metrorrhagia (Spotting)
10/2014
1Urachal adenocarcinoma
10/2014
1Urachal cancer
10/2014
1Primitive Neuroectodermal Tumors (PNET)
01/2014
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2014
1Pulmonary Edema
01/2007
1Dermatitis
03/2006

Drug/Important Bio-Agent (IBA)

5Sorafenib (BAY 43-9006)FDA Link
11/2015 - 01/2014
4pazopanibFDA Link
01/2020 - 11/2014
4Tyrosine Kinase InhibitorsIBA
10/2018 - 05/2014
3EverolimusFDA Link
03/2017 - 01/2014
3Sunitinib (Sutent)FDA Link
11/2015 - 10/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 11/2015
2cabozantinibIBA
12/2016 - 01/2016
2NivolumabIBA
10/2016 - 09/2016
2abirateroneIBA
09/2016 - 06/2016
2Abiraterone AcetateIBA
09/2016 - 10/2015
2Docetaxel (Taxotere)FDA Link
06/2016 - 10/2014
2temsirolimusFDA Link
06/2015 - 04/2015
2Capecitabine (Xeloda)FDA Link
12/2014 - 10/2014
2Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2014 - 10/2014
1OsteopontinIBA
01/2020
1E-SelectinIBA
01/2020
1Interleukin-8 (Interleukin 8)IBA
01/2020
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2020
1Circulating Tumor DNAIBA
10/2018
1Biomarkers (Surrogate Marker)IBA
10/2018
1CytokinesIBA
10/2018
1Vasopressins (Vasopressin)IBA
11/2017
1Prostate-Specific Antigen (Semenogelase)IBA
11/2017
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
10/2016
1LigandsIBA
10/2016
1Monoclonal AntibodiesIBA
09/2016
1Brentuximab VedotinIBA
09/2016
1atezolizumabIBA
09/2016
1pembrolizumabIBA
09/2016
1Prednisone (Sone)FDA LinkGeneric
09/2016
1Immune Checkpoint InhibitorsIBA
09/2016
1Phosphotransferases (Kinase)IBA
06/2015
1TOR Serine-Threonine KinasesIBA
06/2015
1Proteins (Proteins, Gene)FDA Link
06/2015
1XELOXIBA
12/2014
1Soaps (Soap)IBA
11/2014
1Cisplatin (Platino)FDA LinkGeneric
10/2014
1Irinotecan (Camptosar)FDA LinkGeneric
10/2014
1Axitinib (AG 013736)IBA
01/2014
1Angiogenesis InhibitorsIBA
01/2014
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2014
1Oxygen (Dioxygen)IBA
01/2007
1Croton OilIBA
03/2006

Therapy/Procedure

14Therapeutics
10/2018 - 06/2014
5Nephrectomy
10/2018 - 01/2014
4Drug Therapy (Chemotherapy)
01/2019 - 02/2014
4Castration
10/2017 - 10/2015
1Metastasectomy
10/2018
1Combined Modality Therapy
12/2017
1Brachytherapy
11/2017
1Immunotherapy
09/2016
1Time-to-Treatment
04/2015
1Radiotherapy
12/2014